Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution

New hopes for the breast cancer treatment: perspectives on the oncolytic virus therapy

An Advanced Intrahepatic Cholangiocarcinoma Patient Benefits from Personalized Immunotherapy